1. Home
  2. PKE vs VNDA Comparison

PKE vs VNDA Comparison

Compare PKE & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park Aerospace Corp.

PKE

Park Aerospace Corp.

HOLD

Current Price

$31.60

Market Cap

680.4M

Sector

Industrials

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

N/A

Current Price

$5.12

Market Cap

361.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PKE
VNDA
Founded
1954
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
680.4M
361.4M
IPO Year
1994
2005

Fundamental Metrics

Financial Performance
Metric
PKE
VNDA
Price
$31.60
$5.12
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$14.90
AVG Volume (30 Days)
196.0K
715.2K
Earning Date
05-15-2026
05-06-2026
Dividend Yield
1.53%
N/A
EPS Growth
93.10
N/A
EPS
0.17
N/A
Revenue
N/A
$216,105,000.00
Revenue This Year
N/A
$21.35
Revenue Next Year
N/A
$37.40
P/E Ratio
$185.18
N/A
Revenue Growth
N/A
8.72
52 Week Low
$18.19
$4.27
52 Week High
$39.86
$9.91

Technical Indicators

Market Signals
Indicator
PKE
VNDA
Relative Strength Index (RSI) 35.91 40.31
Support Level $30.47 $4.94
Resistance Level $35.94 $5.55
Average True Range (ATR) 1.18 0.19
MACD -0.22 -0.01
Stochastic Oscillator 6.57 4.76

Price Performance

Historical Comparison
PKE
VNDA

About PKE Park Aerospace Corp.

Park Aerospace Corp is an aerospace company that develops and manufactures composite materials used to produce composite structures for the aerospace market. Its products include film adhesives, lightning strike protection materials, specialty ablative materials for rocket motors and nozzles, and materials for radome applications. The Company offers composite materials designed for hand lay-up and automated fiber placement (AFP) manufacturing applications, which are used in jet engines, large and regional transport aircraft, military aircraft, unmanned aerial vehicles (UAVs), business jets, general aviation aircraft, and rotary wing aircraft. It operates in North America, Asia, and Europe, with North America generating maximum revenue.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: